# Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd., Hangzhou, China – FDA Inspections

Source: https://www.keypedia.com/companies/hangzhou-minsheng-binjiang-pharmaceutical-co-ltd/60558281-5fe9-47ef-a772-a976c821d6b2

> Inspection records and compliance data for Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. in Hangzhou. 7 FDA inspections on record, 1 Form 483, last inspected March 07, 2025.

---

## Details

- Name: Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
- FEI Number: 3007498452
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: 658 Bin'An Road, Binjiang District
- City: Hangzhou
- Country Name: China
- Address: 658 Bin'An Road, Binjiang District, Hangzhou, China
- Country: China

## Related Documents

- [483 - Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. - 2025-03-07](https://www.keypedia.com/records/483/hangzhou-minsheng-binjiang-pharmaceutical-co-ltd/2e694383-a505-4680-b521-85714911f8ef) — source: FDA, date: March 7, 2025
- [FDA Inspection 1265022 - Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. - 2025-03-07](https://www.keypedia.com/records/fda_inspections/hangzhou-minsheng-binjiang-pharmaceutical-co-ltd/9173306d-cce2-4074-a429-0c5f2e571d00) — source: FDA, date: March 7, 2025
- FDA Inspection 1107819 - Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. - 2019-09-13 — source: FDA, date: September 13, 2019
- FDA Inspection 1070378 - Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. - 2018-10-18 — source: FDA, date: October 18, 2018
- FDA Inspection 1053977 - Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. - 2018-05-11 — classification: No Action Indicated (NAI), source: FDA, date: May 11, 2018
- [FDA Inspection 990181 - Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. - 2016-07-29](https://www.keypedia.com/records/fda_inspections/hangzhou-minsheng-binjiang-pharmaceutical-co-ltd/97923d47-e3d6-4e95-ab1f-fb4ed076a382) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 29, 2016
- FDA Inspection 879374 - Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. - 2014-04-25 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 25, 2014
- FDA Inspection 732327 - Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. - 2011-06-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 10, 2011

## Related Companies

- [GE Healthcare Shanghai Co., Ltd.](https://www.keypedia.com/companies/ge-healthcare-shanghai-co-ltd/be6327f6-f1a1-40b7-8eb6-9955a9760762)
- [Mylan Laboratories Limited (FDF-2)](https://www.keypedia.com/companies/mylan-laboratories-limited-fdf-2/1bcb64f5-f3f2-412e-81da-b3efab26f310)
- [Mayne Pharma International PTY LTD](https://www.keypedia.com/companies/mayne-pharma-international-pty-ltd/073fd71d-43f6-4a53-9597-0951e7459d08)
- [Leo Pharma A/S](https://www.keypedia.com/companies/leo-pharma-as/8c13d9ad-ead8-4cf4-9308-48b57e826da7)
- [Cosette Pharmaceuticals NC Laboratories, LLC](https://www.keypedia.com/companies/cosette-pharmaceuticals-nc-laboratories-llc/4f90e360-99ea-4457-a022-4950a8ea7644)
- [Eisai, Inc.](https://www.keypedia.com/companies/eisai-inc/1e0d6af4-f962-4ac0-826f-90ce5f71a0a3)
- [Bora Pharmaceuticals Laboratories, Inc](https://www.keypedia.com/companies/bora-pharmaceuticals-laboratories-inc/9bb86ed9-7d7d-4886-a145-b9497462c295)
- [Watson Pharma Private Limited](https://www.keypedia.com/companies/watson-pharma-private-limited/846d9c2f-be10-415a-b681-5436e078ebfd)
- [AstraZeneca Nijmegen B.V.](https://www.keypedia.com/companies/astrazeneca-nijmegen-bv/29dc14a3-b8e5-4e0a-9399-8d18afc9d686)
- [Alphapharm Pty, Ltd.](https://www.keypedia.com/companies/alphapharm-pty-ltd/9007b3c5-9b83-4783-b65d-52eb0246708e)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/khoa-nathan-v-tran/678e5634-237c-4395-88a1-7418479e83c7)
- [Lillian S. Wu](https://www.keypedia.com/people/lillian-s-wu/b1f6643c-ac01-43e5-8ce2-e6f4fdba9d35)